Your browser doesn't support javascript.
loading
Guidelines for mouse and human DC generation.
Lutz, Manfred B; Ali, Shafaqat; Audiger, Cindy; Autenrieth, Stella E; Berod, Luciana; Bigley, Venetia; Cyran, Laura; Dalod, Marc; Dörrie, Jan; Dudziak, Diana; Flórez-Grau, Georgina; Giusiano, Lucila; Godoy, Gloria J; Heuer, Marion; Krug, Anne B; Lehmann, Christian H K; Mayer, Christian T; Naik, Shalin H; Scheu, Stefanie; Schreibelt, Gerty; Segura, Elodie; Seré, Kristin; Sparwasser, Tim; Tel, Jurjen; Xu, Huaming; Zenke, Martin.
Afiliação
  • Lutz MB; Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany.
  • Ali S; Institute of Medical Microbiology and Hospital Hygiene, University of Düsseldorf, Düsseldorf, Germany.
  • Audiger C; Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.
  • Autenrieth SE; Department of Medical Biology, University of Melbourne, Parkville, VIC, 3052, Australia.
  • Berod L; Dendritic Cells in Infection and Cancer (F171), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Bigley V; Department of Internal Medicine II, University of Tübingen, Tübingen, Germany.
  • Cyran L; Institute of Molecular Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, 55131, Germany.
  • Dalod M; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, NE2 4HH, United Kingdom.
  • Dörrie J; Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany.
  • Dudziak D; CNRS, INSERM, Aix Marseille Univ, Centre d'Immunologie de Marseille-Luminy, Turing Center for Living Systems, Marseille, France.
  • Flórez-Grau G; RNA-based Immunotherapy, Hautklinik, Universitätsklinikum Erlangen (UKER), Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany.
  • Giusiano L; Comprehensive Cancer Center Erlangen European Metropolitan Area of Nuremberg (CCC ER-EMN), Östliche Stadtmauerstraße 30, 91054, Erlangen, Germany.
  • Godoy GJ; Deutsches Zentrum Immuntherapie (DZI), Ulmenweg 18, 91054, Erlangen, Germany.
  • Heuer M; Comprehensive Cancer Center Erlangen European Metropolitan Area of Nuremberg (CCC ER-EMN), Östliche Stadtmauerstraße 30, 91054, Erlangen, Germany.
  • Krug AB; Deutsches Zentrum Immuntherapie (DZI), Ulmenweg 18, 91054, Erlangen, Germany.
  • Lehmann CHK; Laboratory of Dendritic Cell Biology, Department of Dermatology, University Hospital Erlangen, Hartmannstraße 14, D-91052, Erlangen, Germany.
  • Mayer CT; Medical Immunology Campus Erlangen (MICE), D-91054, Erlangen, Germany.
  • Naik SH; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, the Netherlands.
  • Scheu S; Institute of Medical Microbiology and Hygiene, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, 55131, Germany.
  • Schreibelt G; Institute of Medical Microbiology and Hygiene, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, 55131, Germany.
  • Segura E; Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany.
  • Seré K; Institute for Immunology, Biomedical Center, Faculty of Medicine, Ludwig-Maximilians-University Munich, Planegg-Martinsried, Germany.
  • Sparwasser T; Laboratory of Dendritic Cell Biology, Department of Dermatology, University Hospital Erlangen, Hartmannstraße 14, D-91052, Erlangen, Germany.
  • Tel J; Medical Immunology Campus Erlangen (MICE), D-91054, Erlangen, Germany.
  • Xu H; Experimental Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
  • Zenke M; Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.
Eur J Immunol ; 53(11): e2249816, 2023 11.
Article em En | MEDLINE | ID: mdl-36303448
ABSTRACT
This article is part of the Dendritic Cell Guidelines article series, which provides a collection of state-of-the-art protocols for the preparation, phenotype analysis by flow cytometry, generation, fluorescence microscopy, and functional characterization of mouse and human dendritic cells (DC) from lymphoid organs and various non-lymphoid tissues. This article provides protocols with top ticks and pitfalls for preparation and successful generation of mouse and human DC from different cellular sources, such as murine BM and HoxB8 cells, as well as human CD34+ cells from cord blood, BM, and peripheral blood or peripheral blood monocytes. We describe murine cDC1, cDC2, and pDC generation with Flt3L and the generation of BM-derived DC with GM-CSF. Protocols for human DC generation focus on CD34+ cell culture on OP9 cell layers for cDC1, cDC2, cDC3, and pDC subset generation and DC generation from peripheral blood monocytes (MoDC). Additional protocols include enrichment of murine DC subsets, CRISPR/Cas9 editing, and clinical grade human DC generation. While all protocols were written by experienced scientists who routinely use them in their work, this article was also peer-reviewed by leading experts and approved by all co-authors, making it an essential resource for basic and clinical DC immunologists.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Dendríticas / Monócitos Tipo de estudo: Guideline Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Dendríticas / Monócitos Tipo de estudo: Guideline Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article